BOTOX WONDERTOX 200

WonderTox 200 – High-Dose, Precision Botulinum Toxin for Advanced Aesthetic and Therapeutic Use

1. Overview & Manufacturer
WonderTox 200 is a botulinum toxin type A developed by Huons Biopharma, a respected pharmaceutical company based in South Korea. As an extension of the WonderTox product line, the 200-unit version is designed for clinics and practitioners who require larger-volume dosing for multi-area aesthetic treatments or therapeutic applications.

2. Packaging & Composition

• Each vial contains 200 units of purified Clostridium botulinum toxin type A in a lyophilized (freeze-dried) powder form.

• The toxin must be reconstituted with sterile saline (0.9% NaCl) before use.

3. Mechanism of Action
WonderTox 200 works by inhibiting acetylcholine release at neuromuscular junctions. This action blocks nerve signals to targeted muscles, resulting in:

• Temporary muscle relaxation

• Reduction of dynamic facial wrinkles

• Control of muscle hyperactivity

• Suppression of sweat gland activity (in hyperhidrosis)

4. Key Features and Advantages

• Double the capacity of WonderTox 100, ideal for full-face treatments, masseter reduction, or larger therapeutic doses

• Rapid onset: Clinical effects typically begin within 2–4 days

• High purity and precision diffusion: Engineered to minimize migration, allowing for controlled and localized results

• Long duration: Results typically last 3–6 months, depending on the treatment area and individual metabolism

• Low immunogenicity: Reduced risk of antibody development due to high purification

5. Clinical Applications

• Aesthetic uses:

  • Forehead lines, glabellar lines, crow’s feet

  • Jaw slimming (masseter hypertrophy)

  • Platysmal band relaxation (neck rejuvenation)

  • Trapezius muscle slimming

• Therapeutic uses:

  • Hyperhidrosis (underarms, palms, soles)

  • Muscle spasticity

  • Chronic migraine (off-label)

  • Bruxism or TMJ tension

6. Certification & Safety

• Manufactured in GMP-compliant facilities

• Approved by the Korean MFDS (Ministry of Food and Drug Safety)

• Undergoing increasing adoption in international markets due to Korea’s rising reputation in biotechnology

7. Storage & Administration

• Store between 2–8°C, protected from light

• Once reconstituted, use within the manufacturer’s recommended timeframe

• Must be administered by a licensed healthcare professional